Pyruvate kinase deficiency in mice protects against malaria
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The global health impact of malaria is enormous, with an estimated 300-500 million clinical cases and 1 million annual deaths. In humans, initial susceptibility to infection with Plasmodium species, disease severity and ultimate outcome of malaria (self-healing or lethal) are under complex genetic control. Alleles associated with sickle cell anemia, beta-thalassemia and deficiency in glucose-6-phosphate dehydrogenase have a protective effect against malaria and may have been retained by positive selection in areas of endemic malaria. Likewise, genetic variations in erythrocyte antigens and levels of host cytokines affect type and severity of disease. A mouse model of infection with Plasmodium chabaudi was used to study the genetic component of malaria susceptibility. Segregation analyses in informative F2 crosses derived from resistant C57BL/6J and susceptible A/J, C3H and SJL strains using extent of blood stage replication of the parasite and survival as traits mapped three P. chabaudi resistance (Char) loci on chromosomes 9 (Char1), 8 (Char2) and 17 (Char3, MHC-linked). Recombinant congenic strains AcB55 and AcB61 are unusually resistant to malaria despite carrying susceptibility alleles at Char1 and Char2. Malaria resistance in AcB55 and AcB61 is associated with splenomegaly and constitutive reticulocytosis, is inherited in an autosomal recessive fashion and is controlled by a locus on chromosome 3 (Char4). Sequencing of candidate genes from the Char4 region identified a loss-of-function mutation (269T-->A, resulting in the amino acid substitution I90N) in the pyruvate kinase gene (Pklr) that underlies the malaria resistance in AcB55 and AcB61. These results suggest that pyruvate kinase deficiency may similarly protect humans against malaria.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recombinant congenic mouse strain AcB61 was generated from A/J and C57BL/6J mice and presents a deficiency in red blood cell pyruvate kinase activity (de novo mutation in Pklr). As a consequence of this mutation, AcB61 mice present chronic hemolytic anemia with tissue iron overload (20–22).”
From Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection (2017) · cites this paper as [20]
In the citing paper
“AcB61 mice harbor a mutation in the gene Pklr leading to PK deficiency and resulting in chronic hemolytic anemia and tissue iron overload (20–22).”
From Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection (2017) · cites this paper as [20]
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
The economic and social burden of malaria
Sachs, J., & Malaney, P. (2002) · Nature · doi:10.1038/415680a · Cited by 2,248 · cited 1×
“gif" NDATA ITEM> ]> The global health impact of malaria is enormous, with an estimated 300–500 million clinical cases and 1 million annual death”
BackgroundNatural resistance to infection with intracellular parasites: isolation of a candidate for Bcg
Vidal, S. M., Malo, D., Vogan, K., Skamene, E., & Gros, P. (1993) · Cell · doi:10.1016/0092-8674(93)90135-d · Cited by 1,104
Self-citationVital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection
Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R. C., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E., Stone, L. R., Scalzo, A. A., & Yokoyama, W. M. (2001) · Science · doi:10.1126/science.1060042 · Cited by 627
Overview of QTL mapping software and introduction to Map Manager QT
Manly, K. F., & Olson, J. M. (1999) · Mammalian Genome · doi:10.1007/s003359900997 · Cited by 448
Genetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444 · cited 1×
“Alleles associated with sickle cell anemia, β-thalassemia and deficiency in glucose-6-phosphate dehydrogenase have a protective effect against malaria and may have been retained by positive selection in areas of endemic malari”
BackgroundLee, S.-H., Girard, S., Macina, D., Busà, M., Zafer, A., Belouchi, A., Gros, P., & Vidal, S. M. (2001) · Nature Genetics · doi:10.1038/ng0501-42 · Cited by 403
Self-citationHaemoglobin C protects against clinical Plasmodium falciparum malaria
Modiano, D., Luoni, G., Sirima, B. S., Simporé, J., Verra, F., Konaté, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M., et al. (2001) · Nature · doi:10.1038/35104556 · Cited by 381 · cited 1×
“, and homozygosity at milder alleles (such as in HbC, α-thalassemi”
Background
Research works printed but not linked: 2
- van Solinge, W.W., Kraaijenhagen, R.J., Rijksen, G. & Nielsen, F.C. Novel mutations in the human red cell type pyruvate kinase gene: two promoter mutations in cis, a splice site mutation, a nonsense- and three missense mutations. Blood 90 Supplement, 1197 (1997).
- Sambrook, J.R. & David, W. Extraction, purification, and analysis of mRNA from eukaryotic cells. in Molecular Cloning: A Laboratory Manual vol. 1 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2001).
Cited by
Missing heritability and strategies for finding the underlying causes of complex disease
Eichler, E. E., Flint, J., Gibson, G., Kong, A., Leal, S. M., Moore, J. H., & Nadeau, J. H. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2809 · Cited by 1,687
“For example, susceptibility to infectious disease has often turned out to be due to variants of large effec”
BackgroundHow Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria
Kwiatkowski, D. P. (2005) · The American Journal of Human Genetics · doi:10.1086/432519 · Cited by 1,104
“In uninfected animals, this mutation causes hemolytic anemia that is compensated by constitutive reticulocytosis and splenomegaly (Min-Oo et al. 2003, 2004).”
BackgroundStrategies for mapping and cloning quantitative trait genes in rodents
Flint, J., Valdar, W., Shifman, S., & Mott, R. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1576 · Cited by 497
Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia
Kuhn, V., Diederich, L., Keller, T. C. S., Kramer, C. M., Lückstädt, W., Panknin, C., Suvorava, T., Isakson, B. E., Kelm, M., & Cortese-Krott, M. M. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6954 · Cited by 469
“…essential for maintaining cell shape and integrity (19, 134, 149, 169); (III) defects in metabolic enzymes catalyzing the pentose phosphate cycle (126, 147) such as deficiency of G6PDH; (IV) redox dysregulation and defects of antioxidant enzymes (63, 84); (V) presence of antibodies directed…”
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
van Wijk, R., & van Solinge, W. W. (2005) · Blood · doi:10.1182/blood-2005-04-1622 · Cited by 352
Human red blood cell polymorphisms and malaria
Williams, T. N. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.009 · Cited by 231
Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis
Lipoldová, M., & Demant, P. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1832 · Cited by 180
Genetic susceptibility to infectious disease
Segal, S., & Hill, A. V. S. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00207-5 · Cited by 170
Genetic variation and susceptibility to infection: the red cell and malaria
Weatherall, D. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07085.x · Cited by 152
“Sequencing of the latter region identified the resistance locus as the pyruvate kinase gene (Pklr; Min-Oo et al, 2003).”
BackgroundMechanisms of genetically-based resistance to malaria
López, C., Saravia, C., Gomez, A., Hoebeke, J., & Patarroyo, M. A. (2010) · Gene · doi:10.1016/j.gene.2010.07.008 · Cited by 166
“Previous “in vivo” studies in mice (Min-Oo et al., 2003) have shown that PK deficiency confers protection to homozygote mice”
BackgroundPyruvate Kinase Deficiency and Malaria
Ayi, K., Min‐Oo, G., Serghides, L., Crockett, M. E., Kirby-Allen, M. A., Quirt, I. C., Gros, P., & Kain, K. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072464 · Cited by 149
Self-citationSalem, S., Salem, D., & Gros, P. (2020) · Human Genetics · doi:10.1007/s00439-020-02154-2 · Cited by 138
Self-citationChiavarina, B., Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Witkiewicz, A. K., Birbe, R., Howell, A., Pestell, R. G., Smith, J., Daniel, R., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.12.18703 · Cited by 128
“Consistent with the idea that cancer cells metabolically exploit host cells as parasites, recent studies have shown that pyruvate kinase deficiency, a common genetic cause of hemolytic anemia, provides protection against malaria in humans(35) and mice.(36) These results suggest that an intact glycolytic pathway in the…”
BackgroundErythrocyte variants and the nature of their malaria protective effect
Min-Oo, G., & Gros, P. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00524.x · Cited by 109
“The AcB55 and AcB61 strains show complex and unique resistance to malaria, characterized by constitutive splenomegaly and reticulocytosis.”
BackgroundInfluentialSelf-citationRed blood cell defects and malaria
Williams, T. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.05.007 · Cited by 113
Genetic control of resistance to human malaria
ALLISON, A. C. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.04.001 · Cited by 114
Turcotte, K., Gauthier, S., Tuite, A., Mullick, A., Malo, D., & Gros, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042170 · Cited by 100
“Sequences were validated by standard dideoxynucleotide sequencing using � -[33P]dATPs ( 43 ).”
MethodSelf-citationBianchi, P. I., Fermo, E., Glader, B. E., Kanno, H., Agarwal, A. M., Barcellini, W., Eber, S., Hoyer, J. D., Kuter, D. J., Maia, T. M., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25325 · Cited by 108
Plasmodium Strain Determines Dendritic Cell Function Essential for Survival from Malaria
Wykes, M., Liu, X. Q., Beattie, L., Stanisic, D. I., Stacey, K. J., Smyth, M. J., Thomas, R., & Good, M. F. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030096 · Cited by 105
“While adhesion of parasitized red blood cells (pRBCs) to the vascular endothelium in the brain [1–4], placenta [5–7], and other tissues is believed to be critical, inflammatory cytokines have been implicated in both human and rodent diseases [8–18].”
Prchal, J. T., & Gregg, X. T. (2005) · Hematology · doi:10.1182/asheducation-2005.1.19 · Cited by 100
How we manage patients with pyruvate kinase deficiency
Grace, R. F., Layton, M., & Barcellini, W. (2019) · British Journal of Haematology · doi:10.1111/bjh.15758 · Cited by 96
Verra, F., Mangano, V. D., & Modiano, D. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01106.x · Cited by 94
Management of pyruvate kinase deficiency in children and adults
Grace, R. F., & Barcellini, W. (2020) · Blood · doi:10.1182/blood.2019000945 · Cited by 89
“Ferritin, ng/mL 63 917 (22-13409) 72 594 (32-8220)”
Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus
Min‐Oo, G., Fortin, A., Pitari, G., Tam, M., Stevenson, M. M., & Gros, P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061252 · Cited by 86
“The PklrI90N mutation causes hemolytic anemia, which, in turn, protects against blood-stage replication of the parasite in AcB55/AcB61, including reduced peak parasitemia, rapid clearance of the parasite, and dramatic increase in survival (28).”
BackgroundInfluentialSelf-citationHost Energy Source Is Important for Disease Tolerance to Malaria
Cumnock, K., Gupta, A. S., Lissner, M. M., Chevée, V., Davis, N. M., & Schneider, D. S. (2018) · Current Biology · doi:10.1016/j.cub.2018.04.009 · Cited by 84
Barker, K. R., Lu, Z., Kim, H., Zheng, Y. Y., Chen, J., Conroy, A. L., Hawkes, M., Cheng, H. S., Njock, M., Fish, J. E., et al. (2017) · Molecular Medicine · doi:10.2119/molmed.2016.00139 · Cited by 79
Single gene effects in mouse models of host: pathogen interactions
Fortier, A., Min-Oo, G., Forbes, J., Lam-Yuk-Tseung, S., & Gros, P. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1004616 · Cited by 71
“A possible contribution of this Char4 locus to malaria resistance in AcB61 could not be formally evaluated, as this strain contains an A/J-derived chromosome 3, and thus, the [AcB61XA]F2 cross is not informative for this chromosome.”
BackgroundInfluentialSelf-citationLovegrove, F. E., Peña‐Castillo, L., Mohammad, N., Liles, W. C., Hughes, T. R., & Kain, K. C. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-295 · Cited by 76
“chabaudi chabaudi [33].”
Forward Genetic Dissection of Immunity to Infection in the Mouse
Vidal, S. M., Malo, D., Marquis, J.-F., & Gros, P. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090304 · Cited by 70
Self-citationGoheen, M. M., Campino, S. G., & Cerami, C. (2017) · British Journal of Haematology · doi:10.1111/bjh.14886 · Cited by 71
“Mouse studies have found that PK deficiency protects against malaria (Min-Oo et al, 2003, 2004), as have other in vitro studies using RBCs from PK-deficient donors (Durand & Coetzer, 2008).”
BackgroundLelliott, P. M., McMorran, B. J., Foote, S. J., & Burgio, G. (2015) · Malaria Journal · doi:10.1186/s12936-015-0809-x · Cited by 66
“Genetic-based deficiencies of pyruvate kinase (PK), a glycolytic enzyme involved in the production of ATP, have been associated with reduced susceptibility to both rodent and human malaria [132, 133].”
BackgroundSafe and Efficient Gene Therapy for Pyruvate Kinase Deficiency
García-Gómez, M., Calabria, A., García-Bravo, M., Benedicenti, F., Kosinski, P. A., López-Manzaneda, S., Hill, C., Mañú‐Pereira, M. D. M., Martín, M. A., Orman, I., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.87 · Cited by 65
“The AcB55 recombinant congenic mice (also recorded as PKD mice) carrying the 269T>A loss-of-function mutation in the Pklr gene, were used throughout.(26,51) AcB55 mice were obtained from Emerillon Therapeutics (Montreal, Quebec, Canada) and maintained at the Animal Facility Laboratory of CIEMAT (registration number ES…”
MethodHost resistance to malaria: using mouse models to explore the host response
Longley, R. J., Smith, C. M., Fortin, A., Berghout, J., McMorran, B. J., Burgio, G., Foote, S. J., & Gros, P. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9302-6 · Cited by 64
“Sequencing of candidate genes in this locus showed that resistance in the AcB55 recombinant congenic mouse was due to a loss-of-function mutation in the pyruvate kinase gene (Min-Oo et al. 2003).”
BackgroundSelf-citationEnterobacteria and host resistance to infection
Kang, E., Crouse, A., Chevallier, L., Pontier, S. M., Zahrani, A. J. A., Silué, N., Campbell‐Valois, F., Montagutelli, X., Gruenheid, S., & Malo, D. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9749-4 · Cited by 59
“Recombinant congenic mouse strains were created by crossing classical inbred mouse strains of differing phenotypes and have been used in several infectious models with complex inheritance (Min-Oo et al. 2003; Roy et al. 2006).”
BackgroundMolecular heterogeneity of pyruvate kinase deficiency
Bianchi, P. I., & Fermo, E. (2020) · Haematologica · doi:10.3324/haematol.2019.241141 · Cited by 55
Boivin, G. A., Pothlichet, J., Skamene, E., Brown, E. G., Loredo‐Osti, J. C., SLADEK, R. M., & Vidal, S. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103320 · Cited by 50
Burgio, G., Baylac, M., Heyer, É., & Montagutelli, X. (2009) · Evolution · doi:10.1111/j.1558-5646.2009.00737.x · Cited by 48
“…the ventral side of the skull), we conducted an analysis of the correlation coefficient between the first PLS scores of those blocks as described by Rohlf and Corti (2000), Bookstein et al. (2003), and applied by Bastir and Rosas (2005), Gunz and Harvati (2007), Mitteroecker and Bookstein (2007)).”
MethodPyruvate kinase deficiency protects against malaria in humans
Durand, P. M., & Coetzer, T. L. (2008) · Haematologica · doi:10.3324/haematol.12450 · Cited by 48
“The data presented in this paper demonstrate for the first time that PK deficient human erythrocytes are resistant to malaria infection in vitro, and support the in vivo findings in the murine model.(1) Two interesting questions arise from this study.”
ResultWillemetz, A., Beatty, S., Richer, E., Rubio, A., Auriac, A., Milkereit, R. J., Thibaudeau, O., Vaulont, S., Malo, D., & Canonne-Hergaux, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00498 · Cited by 45
Reconciling Mouse and Human Immunology at the Altar of Genetics
Gros, P., & Casanova, J. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-065201 · Cited by 45
Self-citationIn Vitro and In Vivo Antimalarial Activity of LZ1, a Peptide Derived from Snake Cathelicidin
Fang, Y., He, X., Zhang, P., Shen, C., Mwangi, J., Xu, C., Mo, G., Lai, R., & Zhang, Z. (2019) · Toxins · doi:10.3390/toxins11070379 · Cited by 42
“In addition, glycolysis is the main pathway for adenosine triphosphate (ATP) production in malaria [22], and its deficiency shows a protective effect against malaria parasite [23,24].”
BackgroundMachado, P., Manco, L., Gomes, C., Mendes, C., Fernandes, N. E. P., Salomé, G., Sitoe, L., Chibute, S., Langa, J. P., Ribeiro, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047071 · Cited by 42
“obtained both in murine models [5] and in Plasmodium falciparum in vitro cultures using human PK-deficient blood [6,7].”
BackgroundModulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population
van Bruggen, R., Gualtieri, C. O., Iliescu, A., Cheepsunthorn, C. L., Mungkalasut, P., Trape, J., Modiano, D., Sirima, B. S., Singhasivanon, P., Lathrop, M. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144555 · Cited by 39
“chabaudi AS, these Pklr-deficient mice show decreased peak parasitemia and decreased mortality [31, 32].”
BackgroundSelf-citationPyruvate Kinase Deficiency: Current Challenges and Future Prospects
Fattizzo, B., Cavallaro, F., Marcello, A. P., Vercellati, C., & Barcellini, W. (2022) · Journal of Blood Medicine · doi:10.2147/jbm.s353907 · Cited by 37
Malaria: looking for selection signatures in the human PKLR gene region
Machado, P., Pereira, R., Rocha, A. M., Manco, L., Fernandes, N. E. P., Miranda, J., Ribeiro, L., do Rosário, V. E., Amorim, A., Gusmão, L., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08165.x · Cited by 37
“More recently, pyruvate kinase (PK)-deficiency has also been reported as protective against malaria in murine models (Min-Oo et al, 2003) and two studies have reported the in vitro culturing of P. falciparum in PKdeficient blood with a significant decrease in parasite replication (Ayi et al, 2008;…”
BackgroundRescue of Pyruvate Kinase Deficiency in Mice by Gene Therapy Using the Human Isoenzyme
Meza, N. W., Alonso-Ferrero, M. E., Navarro, S., Bustamante, O. Q., Valeri, A., García-Gómez, M., Bueren, J. A., Bautista, J. M., & Segovia, J. C. (2009) · Molecular Therapy · doi:10.1038/mt.2009.200 · Cited by 37
Bopp, S. E. R., Ramachandran, V., Henson, K., Luzader, A., Lindstrom, M., Spooner, M., Steffy, B. M., Suzuki, O., Janse, C. J., Waters, A. P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010903 · Cited by 36
“For example the protective aspect of pyruvate kinase deficiency was first identified in the mouse model [34] and has subsequently been linked to resistance in human populations as”
BackgroundKobets, T., Havelková, H., Grekov, I., Volkova, V., Vojtíšková, J., Slapničková, M., Kurey, I., Sohrabi, Y., Svobodová, M., Démant, P., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001667 · Cited by 36
“Such genes were indicated also by results of Anderson and coworkers [16] who found that strains BALB/c and C57BL/6 had similar numbers of parasites in ear dermis and exhibited similar ear lesion development after infection with L. tropica.”
BackgroundAyi, K., Liles, W. C., Gros, P., & Kain, K. C. (2009) · The Journal of Infectious Diseases · doi:10.1086/605843 · Cited by 36
Self-citationRoy, M.-F., Riendeau, N., Loredo‐Osti, J., & Malo, D. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364344 · Cited by 36
Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice
Roy, M.-F., Riendeau, N., Bédard, C., Hélie, P., Min-Oo, G., Turcotte, K., Gros, P., Canonne-Hergaux, F., & Malo, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062606 · Cited by 35
Self-citationPhenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model
Min-Oo, G., Fortin, A., Tam, M.-F., Gros, P., & Stevenson, M. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364069 · Cited by 35
Self-citationGenetic resistance to malaria in mouse models
Hernandez-Valladares, M., Naessens, J., & Iraqi, F. A. (2005) · Trends in Parasitology · doi:10.1016/j.pt.2005.06.010 · Cited by 35
The impact of genomics on the analysis of host resistance to infectious disease
Tuite, A. R., & Gros, P. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.11.016 · Cited by 33
Self-citationCaignard, G., Eva, M. M., van Bruggen, R., Eveleigh, R. J. M., Bourque, G., Malo, D., Gros, P., & Vidal, S. M. (2014) · Genes · doi:10.3390/genes5040887 · Cited by 32
Self-citationHortle, E., Nijagal, B., Bauer, D. C., Jensen, L. M., Ahn, S. B., Cockburn, I. A., Lampkin, S., Tull, D., McConville, M. J., McMorran, B. J., et al. (2016) · Blood · doi:10.1182/blood-2015-09-666834 · Cited by 32
“The Ampd3 mutation stimulates reticulocytosis during infection Mice carrying the Ampd3 allele exhibit splenomegaly, which is positively correlated with malaria resistance.(32,33) Therefore, it is possible that the spleenmediates malaria resistance in the Ampd3 line.”
BackgroundCysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium
Min‐Oo, G., Ayi, K., Bongfen, S. E., Tam, M., Radovanovic, I., Gauthier, S., Santiago, H. C., Rothfuchs, A. G., Roffê, E., Sher, A., et al. (2010) · Experimental Parasitology · doi:10.1016/j.exppara.2010.02.009 · Cited by 32
“Using positional cloning, we have shown that the protective effect of the Char4 locus is caused by a loss-of-function mutation in the erythrocyte form of pyruvate kinase (PklrI90N) (Min-Oo et al., 2003; Min-Oo et al., 2004).”
BackgroundSelf-citationLaroque, A., Min‐Oo, G., Tam, M., Radovanovic, I., Stevenson, M. M., & Gros, P. (2011) · Genes and Immunity · doi:10.1038/gene.2011.67 · Cited by 31
“The Char4 protective effect is caused by homozygosity for a mutation (Pklr I90N ) in the RBC form of pyruvate kinase (Pklr) 29; 30 .”
Self-citationGenetic diversity in human erythrocyte pyruvate kinase
Berghout, J., Higgins, S. J., Loucoubar, C., Sakuntabhai, A., Kain, K. C., & Gros, P. (2011) · Genes and Immunity · doi:10.1038/gene.2011.54 · Cited by 31
Self-citationMin‐Oo, G., Fortin, A., Poulin, J., & Gros, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01719-09 · Cited by 31
Self-citationFamilial erythrocytosis: molecular links to red blood cell control
Percy, M. J., & Lee, F. S. (2008) · Haematologica · doi:10.3324/haematol.13250 · Cited by 25
Functional analysis of erythrocyte determinants of Plasmodium infection
Bei, A. K., & Duraisingh, M. T. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.03.006 · Cited by 29
“…(Allison et al., 1961; Allison and Clyde, 1961; Gilles et al., 1967; Ruwende and Hill, 1998), and it has been postulated based on studies in mice (Min-Oo et al., 2003; Ayi et al., 2004, 2008) that pyruvate kinase deficiencies could also provide protection in humans (Daily and Sabeti, 2008);…”
BackgroundPrevalence of β-Thalassemia Trait and Glucose-6-Phosphate Dehydrogenase Deficiency in Iranian Jews
Karimi, M., Yavarian, M., Afrasiabi, A., Dehbozorgian, J., & Rachmilewitz, E. A. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.09.001 · Cited by 27
“, Duffy blood group (20), CD40 (21), glycophorins (22), and pyruvate kinase (23).”
BackgroundRadiation-Induced Lung Response of AcB/BcA Recombinant Congenic Mice
Lemay, A., & Haston, C. K. (2008) · Radiation Research · doi:10.1667/rr1319.1 · Cited by 27
Alves, J., Machado, P., Silva, J. S., Gonçalves, N., Ribeiro, L., Faustino, P., do Rosário, V. E., Manco, L., Gusmão, L., Amorim, A., et al. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.09.008 · Cited by 28
Malaria Liver Stage Susceptibility Locus Identified on Mouse Chromosome 17 by Congenic Mapping
Gonçalves, L. A., Almeida, P., Mota, M. M., & Penha‐Gonçalves, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001874 · Cited by 26
“infection involving increased splenic clearance of erythrocytes through hemolysis”
BackgroundMin‐Oo, G., Tam, M., Stevenson, M. M., & Gros, P. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.03.003 · Cited by 25
Self-citationCharacterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3
Meunier, C., Cai, J., Fortin, A., Kwan, T., Marquis, J. F., Turbide, C., Kraak, L. V. D., Jothy, S., Beauchemin, N., & Gros, P. (2009) · Oncogene · doi:10.1038/onc.2009.369 · Cited by 24
“On the other hand, a reciprocal set of RCS, BcA71, BcA72 and BcA87 showed susceptibility discordant with their parental B6 control due to an A/J-derived segment, suggesting the segregation of a major cancer susceptibility gene in those strains.”
BackgroundSelf-citationMeadows, D. N., Pyzik, M., Wu, Q. H., Torre, S., Gros, P., Vidal, S. M., & Rozen, R. R. (2014) · Human Mutation · doi:10.1002/humu.22533 · Cited by 23
Self-citationHernandez-Valladares, M., Rihet, P., & Iraqi, F. A. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00044.2013 · Cited by 23
Hereditary red cell disorders and malaria resistance
Durand, P. M., & Coetzer, T. L. (2008) · Haematologica · doi:10.3324/haematol.13371 · Cited by 23
Host Genetic Factors in Resistance and Susceptibility to Malaria
Kwiatkowski, D. P., & Luoni, G. (2014) · ASM Press eBooks · doi:10.1128/9781555817558.ch24 · Cited by 22
Strain-specific differences in the genetic control of two closely related mycobacteria
Di Pietrantonio, T., Hernandez, C., Girard, M., Verville, A., Orlova, M., Belley, A., Behr, M. A., Loredo-Osti, J. C., & Schurr, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001169 · Cited by 21
“However, RC strains have also proven useful for positional identification of disease susceptibility loci by employing RC strains with extreme phenotypes in subsequent genetic crosses [39,40,41].”
BackgroundGenetic Analysis of Resistance to Infections in Mice: A/J meets C57BL/6J
Marquis, J. F., & Gros, P. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-75203-5_2 · Cited by 21
Self-citationHost genetics in malaria: lessons from mouse studies
Huang, H., McMorran, B. J., Foote, S. J., & Burgio, G. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9744-9 · Cited by 20
The missing heritability in type 1 diabetes
Pang, H., Lin, J., Luo, S., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14777 · Cited by 20
Mouse models for the genetic study of tuberculosis susceptibility
Pietrantonio, T. D., & Schurr, E. (2005) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/4.3.277 · Cited by 19
“Such an approach has been used in a mouse model of malaria.(121) Another largely unknown side of the host response to M.”
MethodMapping of Char10, a novel malaria susceptibility locus on mouse chromosome 9
Min‐Oo, G., Willemetz, A., Tam, M., Canonne‐Hergaux, F., Stevenson, M. M., & Gros, P. (2009) · Genes and Immunity · doi:10.1038/gene.2009.78 · Cited by 18
Self-citationRed cell polymorphisms and malaria: an evolutionary approach
Bauduer, F. (2012) · Bulletins et Mémoires de la Société d anthropologie de Paris · doi:10.1007/s13219-012-0060-8 · Cited by 15
“• an in vivo model demonstrating resistance in PK deficient mice has been developed [67].”
BackgroundYavarian, M., Karimi, M., Shahriary, M., & Afrasiabi, A. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.08.008 · Cited by 14
Chromosomal mapping of host resistance loci to Trichinella spiralis nematode infection in rats
Suzuki, T., Ishih, A., Kino, H., Muregi, F. W., Takabayashi, S., Nishikawa, T., Takagi, H., & Terada, M. (2006) · Immunogenetics · doi:10.1007/s00251-005-0079-9 · Cited by 13
“Linkage mapping techniques to detect quantitative trait loci (QTLs) using the progeny derived from two parental strains that show clear different phenotypes could lead to fine mapping and/or identification of the specific molecules (Iraqi et al. 2000; Min-Oo et al. 2003).”
BackgroundA contribuição dos polimorfismos humanos do eritrócito na proteção contra a malária
Machado, P., Mendes, C., do Rosário, V. E., & Arez, A. P. (2010) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232010000400013 · Cited by 13
Controlling malaria and African trypanosomiasis: The role of the mouse
Foote, S. J., Iraqi, F., & Kemp, S. J. (2005) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/4.3.214 · Cited by 12
“Despite lower parasitaemia, AcB55 and another congenic strain, AcB61, showed significant pathology (splenomegaly, a low number of erythrocytes and a high reticulocyte concentration) when compared with the parental strains.(29,30) Sequence analyses of char4 candidate genes revealed a mutant liver and red cell-specific…”
ResultMiscellanea on Encephalopathies
Legname, G., & Zanusso, G. (2012) · InTech eBooks · doi:10.5772/1191 · Cited by 11
Xu, G., van Bruggen, R., Gualtieri, C. O., Moradin, N., Fois, A., Vallerand, D., Russo, M. D. S. T., Bassenden, A. V., Lu, W., Tam, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108170 · Cited by 11
“Reduced ATP levels have been associated with decreased permissiveness of Plasmodium replication in mouse and human models of PKLR defi-ciency (Ayi et al., 2009; Min-Oo et al., 2003).”
Self-citationMeunier, C., Kwan, T., Turbide, C., Beauchemin, N., & Gros, P. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15817 · Cited by 10
Self-citationHuman Genetics and Malaria: Relevance for the Design of Clinical Trials
Parikh, S., & Rosenthal, P. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/592223 · Cited by 10
Can nature's defence against malaria be mimicked by the development of host-directed therapies?
Foote, S. J. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500241 · Cited by 9
A Malaria Fingerprint in the Human Genome?
Daily, J. P., & Sabeti, P. C. (2008) · New England Journal of Medicine · doi:10.1056/nejme0801414 · Cited by 9
“builds on the established association between pyruvate kinase deficiency and protection from disease in a mouse model of malaria.(6,7) The study shows that the extent of infection and replication of Plasmodium falciparum in vitro is significantly decreased in erythrocytes that are deficient in pyruvate kinase, as comp…”
BackgroundLaroque, A., Min‐Oo, G., Tam, M., Ponka, P., Stevenson, M. M., & Gros, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177818 · Cited by 8
Self-citationNavarro, S., Bustamante, O. Q., Sánchez‐Domínguez, R., López-Manzaneda, S., Ojeda-Pérez, I., García-Torralba, A., Alberquilla, O., Law, K., Beard, B. C., Bastone, A. L., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.07.006 · Cited by 8
“A minimum vector copy number (VCN) of 0.2 0.3 was required to correct PKD when corrected cells were transplanted in a mouse model for PKD. Biodistribution and pharmacokinetics studies, with the aim of conducting a global gene therapy clinical trial for PKD patients (RP-L301-0119), demonstrated that genetically correct…”
MethodInfluentialMorais, I., Medeiros, M. M., de Carvalho, M. E., Morelló, J., Teixeira, S. M., Maciel, S., Nhantumbo, J., Balau, A., Rosa, M. T. G., Nogueira, F., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.840968 · Cited by 8
“PKD was associated with resistance to malaria (Min-Oo et al., 2003; Laroque et al., 2017) and babesiosis (Oka et al.”
BackgroundDisease Tolerance: Linking Sickness Behaviours to Metabolism Helps Mitigate Malaria
Vale, P. F. (2018) · Current Biology · doi:10.1016/j.cub.2018.04.031 · Cited by 7
Mouse NC/Jic strain provides novel insights into host genetic factors for malaria research
Ohno, T., Miyasaka, Y., Kuga, M., Ushida, K., Matsushima, M., Kawabe, T., Kikkawa, Y., Mizuno, M., & Takahashi, M. (2019) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.18-0185 · Cited by 6
Biphosphoglycerate Mutase: A Novel Therapeutic Target for Malaria?
Azzuolo, A., Yang, Y., Berghuis, A. M., Fodil, N., & Gros, P. (2023) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2023.150748 · Cited by 6
Self-citationEnergy Metabolism as an Antimalarial Drug Target
Jortzik, E., & Becker, K. (2011) · Wiley eBooks · doi:10.1002/9783527633883.ch5 · Cited by 5
FREQUENCY OF PYRUVATE KINASE (PK) DEFICIENCY IN NEONATES WITH HAEMOLYTIC ANAEMIA
Rehman, J. U., Ahmed, S., Bhatti, F. A., & Ali, N. (2015) · Pakistan Armed Forces Medical Journal · Cited by 5
Mungkalasut, P., Kiatamornrak, P., Jugnam-Ang, W., Krudsood, S., Cheepsunthorn, P., & Cheepsunthorn, C. L. (2022) · Malaria Journal · doi:10.1186/s12936-022-04267-7 · Cited by 5
Wiltshire, S. A., Diez, E., Miao, Q., Dubé, M., Gagné, M., Paquette, O., Lafrenière, R. G., Ndao, M., Castellani, L. W., Skamene, E., et al. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00025.2012 · Cited by 4
Self-citationComparative proteomic and bioinformatic analysis of Theileria luwenshuni and Theileria uilenbergi
Zhang, X., Li, Y., Chen, Z., Liu, Z., Ren, Q., Yang, J., Xinquan, Z., Guan, G., Liu, A., Luo, J., et al. (2016) · Experimental Parasitology · doi:10.1016/j.exppara.2016.03.019 · Cited by 3
Metadata
- Authors
- Min-Oo, G., Fortin, A., Tam, M.-F., Nantel, A., Stevenson, M. M., & Gros, P.
- Affiliations
- McGill University (CA)
- Biotechnology Research Institute (CA)
- Montreal General Hospital (CA)
- Corresponding author
- Gros, Philippe
- Venue
- Nature Genetics
- Published
- 2003-11-02
- Volume
- 35
- Issue
- 4
- Pages
- 357-362
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2092433469
- Cited by
- 133
- References
- 29
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 8 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 9
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- NPARC (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Physiology (medical) › Erythrocyte Function and Pathophysiology
- Keywords
- pyruvate kinase deficiency, malaria resistance, Plasmodium chabaudi, PKLR gene, recombinant congenic strains, loss-of-function mutations, autosomal recessive inheritance, splenomegaly, reticulocytosis, host genetic susceptibility
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Erythrocytes, Female, Immunity, Innate, Genetic Linkage, Malaria, Male, Mice, Inbred A, Mice, Inbred C57BL, Mice, Inbred DBA, Molecular Sequence Data, Pyruvate Kinase, Sequence Homology, Nucleic Acid, Splenomegaly, Plasmodium chabaudi, Parasitemia, Amino Acid Substitution, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.